uniQure N.V. (QURE)
Healthcare • Biotechnology
StockNasdaqGSNetherlandsNL0010696654
23.54 USD
-4.43% today Updated 13 Nov 2026 15:24
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by uniQure N.V., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:24. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
02 Mar 2027
in 109 days · 08:00 · estimate -0.73
Last results
-0.78 vs -0.82 estimated
04 Nov 2026 · Beat +4.5%
Beat the estimate
7 of 12
5 missed · 0 in line
Average surprise
-16.8%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 02 Mar 2027 08:00 | -0.73 | — | — | Upcoming |
| 04 Nov 2026 07:00 | -0.82 | -0.78 | +4.5% | Beat |
| 29 Jul 2026 07:00 | -0.71 | -1.07 | -51.3% | Miss |
| 05 May 2026 07:00 | -0.75 | -0.73 | +3.3% | Beat |
| 02 Mar 2026 07:00 | -0.78 | -0.47 | +39.3% | Beat |
| 10 Nov 2025 07:00 | -0.75 | -1.19 | -59.8% | Miss |
| 29 Jul 2025 07:00 | -0.76 | -0.60 | +21.1% | Beat |
| 09 May 2025 07:00 | -0.93 | -0.73 | +22.1% | Beat |
| 27 Feb 2025 08:00 | -0.52 | -1.44 | -178.8% | Miss |
| 05 Nov 2024 07:00 | -0.93 | -0.84 | +9.8% | Beat |
| 01 Aug 2024 07:00 | -1.16 | -1.08 | +7.1% | Beat |
| 07 May 2024 07:00 | -1.16 | -1.26 | -8.7% | Miss |
| 28 Feb 2024 07:00 | -1.28 | -1.41 | -10.1% | Miss |
| 07 Nov 2023 07:00 | -0.72 | -1.75 | -142.1% | Miss |
| 01 Aug 2023 07:00 | 2.81 | -1.31 | -146.4% | Miss |
| 09 May 2023 07:00 | -0.87 | -1.48 | -69.9% | Miss |
| 27 Feb 2023 07:00 | -0.81 | 0.14 | +117.6% | Beat |
| 02 Nov 2022 07:00 | -1.11 | -1.03 | +7.1% | Beat |
| 08 Aug 2022 07:00 | -0.91 | -0.83 | +9.3% | Beat |
| 02 May 2022 07:00 | -0.79 | -0.95 | -20.7% | Miss |
| 25 Feb 2022 07:00 | -0.69 | 0.15 | +121.8% | Beat |
| 25 Oct 2021 07:00 | -0.91 | -0.68 | +25.5% | Beat |
| 26 Jul 2021 07:00 | 2.18 | 7.23 | +231.3% | Beat |
| 10 May 2021 07:00 | -0.77 | -0.75 | +2.3% | Beat |
| 01 Mar 2021 07:00 | 0.79 | -0.01 | -101.1% | Miss |
| 27 Oct 2020 07:00 | -0.76 | -1.02 | -35.2% | Miss |
| 30 Jul 2020 07:00 | -0.52 | -0.82 | -56.3% | Miss |
| 29 Apr 2020 06:00 | -0.73 | -0.58 | +20.7% | Beat |
| 02 Mar 2020 16:00 | -0.64 | -0.87 | -35.6% | Miss |
| 28 Oct 2019 07:00 | -0.74 | -0.52 | +28.9% | Beat |
| 29 Jul 2019 07:00 | -0.67 | -0.75 | -11.8% | Miss |
| 29 Apr 2019 07:00 | -0.63 | -0.66 | -5.8% | Miss |
| 28 Feb 2019 07:00 | -0.58 | -0.52 | +10.7% | Beat |
| 06 Nov 2018 06:00 | -0.54 | -0.52 | +4.4% | Beat |
| 08 Aug 2018 07:00 | -0.52 | -0.49 | +5.7% | Beat |
| 30 Apr 2018 07:00 | -0.61 | -0.49 | +20.0% | Beat |
| 14 Mar 2018 07:00 | -0.63 | -0.74 | -16.6% | Miss |
| 01 Nov 2017 06:00 | -0.54 | -0.34 | +35.8% | Beat |
| 08 Aug 2017 07:00 | -0.71 | -0.71 | +1.0% | In line |
| 09 May 2017 07:00 | -0.58 | -0.74 | -26.6% | Miss |
| 15 Mar 2017 07:00 | -0.55 | -0.55 | +1.1% | Beat |
| 22 Nov 2016 07:00 | -0.77 | -0.54 | +29.6% | Beat |
| 25 Aug 2016 16:00 | -0.78 | -0.77 | +0.7% | In line |
| 31 May 2016 05:00 | -0.68 | -0.83 | -22.8% | Miss |
| 04 Apr 2016 07:00 | -0.61 | -0.48 | +20.7% | Beat |
| 30 Nov 2015 07:00 | -0.72 | -0.67 | +6.5% | Beat |
| 27 Aug 2015 05:00 | 0.36 | -0.87 | -343.2% | Miss |
| 11 Jun 2015 05:00 | -0.40 | -0.69 | -72.6% | Miss |
| 06 Apr 2015 08:00 | -0.52 | -0.62 | -19.4% | Miss |
| 01 Dec 2014 06:00 | -0.53 | -0.51 | +3.8% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 16.1M | -40.6% | -199M | -1,236.0% | -3.46 | +29.7% | -178.4M |
| 2024 | 27.1M | +71.2% | -239.6M | -883.4% | -4.92 | +24.0% | -194.4M |
| 2023 | 15.8M | -85.1% | -308.5M | -1,947.1% | -6.47 | -138.7% | -153.1M |
| 2022 | 106.5M | — | -126.8M | -119.1% | -2.71 | — | -162.7M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 13 Nov 2026 | 24.50 | 24.50 | 23.34 | 23.80 | -3.37% | 182,847 | |
| 12 Nov 2026 | 24.18 | 26.20 | 24.01 | 24.63 | +0.18% | 2,133,200 | |
| 11 Nov 2026 | 22.89 | 24.66 | 22.75 | 24.58 | +8.26% | 2,465,300 | |
| 10 Nov 2026 | 22.45 | 23.72 | 22.21 | 22.71 | -0.35% | 1,137,500 | |
| 09 Nov 2026 | 21.70 | 23.01 | 21.13 | 22.79 | +5.02% | 1,322,300 | |
| 06 Nov 2026 | 21.25 | 21.93 | 21.09 | 21.70 | +3.28% | 1,172,900 | |
| 05 Nov 2026 | 22.48 | 22.68 | 20.58 | 21.01 | -8.77% | 5,134,200 | |
| 04 Nov 2026 | 24.10 | 24.22 | 21.51 | 23.03 | -3.52% | 2,661,100 | |
| 03 Nov 2026 | 23.27 | 24.09 | 22.87 | 23.87 | +3.92% | 1,838,900 | |
| 02 Nov 2026 | 26.22 | 26.60 | 22.42 | 22.97 | -7.49% | 6,440,800 | |
| 1,246 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Reduced Loss And Higher Revenue Could Shift The Case For uniQure Stock (opens in a new tab) Simply Wall St. · 06 Nov 2026 02:16
- uniQure N.V. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 04 Nov 2026 22:55
- uniQure NV (QURE) (Q3 2026) Earnings Call Highlights: FDA Priority Review for AMT-130 and a ... (opens in a new tab) GuruFocus.com · 04 Nov 2026 21:11
- uniQure (QURE) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 04 Nov 2026 19:45
- uniQure Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 04 Nov 2026 19:14
- uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates (opens in a new tab) Zacks · 04 Nov 2026 12:55
- UniQure: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 04 Nov 2026 12:25
- Uniqure Stock Falls After Its Huntington's Gene Therapy Lands At The FDA (opens in a new tab) Investor's Business Daily · 02 Nov 2026 21:08
- uniQure stock jumps as FDA accepts Huntington’s therapy filing (opens in a new tab) Investing.com · 02 Nov 2026 14:59
- 3 Promising Genomics Stocks to Add to Your Portfolio Now (opens in a new tab) Zacks · 30 Oct 2026 13:09
- uniQure (QURE) Stock Could Be Overvalued Despite A Securities Investigation (opens in a new tab) Simply Wall St. · 29 Oct 2026 10:21
- Why uniQure (QURE) Is Down 5.9% After Fresh Huntington’s Gene Therapy Data Update And What’s Next (opens in a new tab) Simply Wall St. · 07 Oct 2026 14:09
- uniQure (QURE) Faces A Fresh AMT 130 Test After Mixed Data, Bargain Or Trap (opens in a new tab) Simply Wall St. · 01 Oct 2026 06:09
- uniQure Plunges on Additional Data From Huntington's Disease Study (opens in a new tab) Zacks · 30 Sep 2026 17:47
- uniQure Stock Crashed on Its Huntington’s Data. Wall Street’s Price Target Says the Selloff Went Too Far (opens in a new tab) 24/7 Wall St. · 30 Sep 2026 16:48
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 24.63 USD
- Market cap
- 1.7B
- Exchange
- NasdaqGS
- Country
- Netherlands
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow QURE and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.